Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas
Bidisha Bhattacharya, … , William Bishai, Igor Kramnik
Bidisha Bhattacharya, … , William Bishai, Igor Kramnik
Published December 10, 2020
Citation Information: J Clin Invest. 2021;131(3):e130319. https://doi.org/10.1172/JCI130319.
View: Text | PDF
Research Article Immunology Infectious disease

The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas

  • Text
  • PDF
Abstract

The mechanism by which only some individuals infected with Mycobacterium tuberculosis develop necrotic granulomas with progressive disease while others form controlled granulomas that contain the infection remains poorly defined. Mice carrying the sst1-suscepible (sst1S) genotype develop necrotic inflammatory lung lesions, similar to human tuberculosis (TB) granulomas, which are linked to macrophage dysfunction, while their congenic counterpart (B6) mice do not. In this study we report that (a) sst1S macrophages developed aberrant, biphasic responses to TNF characterized by superinduction of stress and type I interferon pathways after prolonged TNF stimulation; (b) the late-stage TNF response was driven via a JNK/IFN-β/protein kinase R (PKR) circuit; and (c) induced the integrated stress response (ISR) via PKR-mediated eIF2α phosphorylation and the subsequent hyperinduction of ATF3 and ISR-target genes Chac1, Trib3, and Ddit4. The administration of ISRIB, a small-molecule inhibitor of the ISR, blocked the development of necrosis in lung granulomas of M. tuberculosis–infected sst1S mice and concomitantly reduced the bacterial burden. Hence, induction of the ISR and the locked-in state of escalating stress driven by the type I IFN pathway in sst1S macrophages play a causal role in the development of necrosis in TB granulomas. Interruption of the aberrant stress response with inhibitors such as ISRIB may offer novel host-directed therapy strategies.

Authors

Bidisha Bhattacharya, Shiqi Xiao, Sujoy Chatterjee, Michael Urbanowski, Alvaro Ordonez, Elizabeth A. Ihms, Garima Agrahari, Shichun Lun, Robert Berland, Alexander Pichugin, Yuanwei Gao, John Connor, Alexander R. Ivanov, Bo-Shiun Yan, Lester Kobzik, Bang-Bon Koo, Sanjay Jain, William Bishai, Igor Kramnik

×

Figure 5

Transcriptional control of IFN-β superinduction in B6.Sst1S macrophages by TNF.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptional control of IFN-β superinduction in B6.Sst1S macrophages ...
(A) Effects of TNF stimulation and siRNA knockdown on IRF1 protein expression in WT B6 and B6.Sst1S BMDMs stimulated with 10 ng/mL TNF for 24 hours. un, no TNF treatment; sc, scrambled siRNA control. (B) Inhibition of IFN-β mRNA expression in TNF-stimulated WT B6 and B6.Sst1S BMDMs after IRF1, IRF3, and IRF7 knockdown using siRNA. Percentage inhibition was calculated as compared to scrambled siRNA control. (C) Effects of TNF neutralization and IFNAR1 blockade on IFN-β mRNA expression in B6.Sst1S BMDMs treated with TNF for 16 hours. The anti-IFNAR1, anti–TNF-α, and isotype control antibodies were added at time points indicated on the x axis. (D) Effect of TBK1, PKR, JNK, and NF-κB inhibitors added after 12 hours of TNF stimulation on IFN-β mRNA levels in B6.Sst1S BMDMs treated at 16 hours. (E) Transcription factor (TF) binding activities in WT B6 and B6.Sst1S BMDMs after TNF stimulation for 12 hours. (F and G) Kinetics of Hspa1a mRNA (F) and HSPA1A protein (G) expression in WT B6 and B6.Sst1S BMDMs stimulated with TNF. (H) Aggresome formation in B6 and B6.Sst1S BMDMs stimulated with TNF for 24 hours. Lower panels = effects of the rocaglate (50 nM) and BHA (100 μM) treatments on aggresome formation in B6.Sst1S BMDMs. (I and J) Effects of rocaglate treatment (50 nM) on superinduction of Hspa1a (I) and IFN-β (J) mRNAs in TNF-stimulated B6.Sst1S BMDMs. (K) Suppression of the TNF-induced Hspa1a and IFN-β mRNA upregulation in B6.Sst1S macrophages (at 18 hours) using BHA added at 0 or 12 hours of TNF treatment. Fold induction of gene expression in panels D, F, I, and J was calculated relative to the mRNA expression in untreated B6 macrophages. In panels B–D, F, and I–K, 2-way ANOVA with Tukey’s post hoc test was used on combined data of 3 independent experiments (*P = 0.01–0.05; **P < 0.01; ***P < 0.001). NS, not significant.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts